National Enzyme Company

Prairie Capital Fund V

Manufacturer of FDA-compliant specialty enzymes and digestive health products to the U.S. and global vitamins, minerals, and supplements industry

Location: Forsythe, MO

Investment Date: October 2015

Industry: Consumer, Healthcare

Exit Date: July 2018

Buyer: Deerland Probiotics & Enzymes (RoundTable Healthcare Partners Portfolio Company)

“My staff and I rate their professionalism, honesty and genuine friendliness second to none. Right from the start, we knew the principals were very interested in the business and the right outcome for both parties. Every conversation involved complete team participation.

A few years later, I can say it’s been an absolute pleasure working with Prairie. They are “noses in, hands off”, just as they promised. They care about the well being of all employees, not just senior staff.

Bottom line: After 47 years in business, the Prairie transaction was the best and most enjoyable acquisition transaction of my career.”

Charlie Amidon

Former President and COO

Investment Team

Sean McNally
Sean McNally
Partner